HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yasuhiro Kondoh Selected Research

Ulcerative Colitis

1/2020Mesalazine-induced lung injury with severe respiratory failure successfully treated with steroids and non-invasive positive pressure ventilation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yasuhiro Kondoh Research Topics

Disease

38Idiopathic Pulmonary Fibrosis
01/2022 - 03/2007
24Interstitial Lung Diseases (Interstitial Lung Disease)
03/2021 - 02/2005
9Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2022 - 05/2006
9Bronchiectasis
01/2021 - 06/2002
8Connective Tissue Diseases (Connective Tissue Disease)
01/2022 - 01/2014
8Dyspnea (Shortness of Breath)
11/2021 - 03/2011
7Fibrosis (Cirrhosis)
01/2022 - 10/2002
6Disease Progression
01/2021 - 07/2011
5COVID-19
08/2022 - 01/2020
5Respiratory Insufficiency (Respiratory Failure)
12/2021 - 01/2010
5Pulmonary Hypertension
01/2021 - 03/2011
4Systemic Scleroderma (Systemic Sclerosis)
11/2022 - 01/2020
4Chronic Obstructive Pulmonary Disease (COPD)
01/2021 - 06/2005
4Lung Injury
01/2020 - 04/2006
4Vascular Diseases (Vascular Disease)
01/2020 - 03/2007
3Acute Lung Injury
01/2022 - 06/2011
3Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2022 - 01/2020
3Pneumonia (Pneumonitis)
01/2020 - 01/2019
3Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2017 - 01/2010
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
02/2022 - 04/2014
2Exanthema (Rash)
02/2022 - 01/2012
2Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis)
07/2016 - 03/2007
2Pulmonary Tuberculosis
01/2016 - 01/2010
2Lung Neoplasms (Lung Cancer)
01/2013 - 04/2006
1Rheumatic Diseases (Rheumatism)
11/2022
1Neoplasms (Cancer)
11/2022
1Idiopathic Interstitial Pneumonias
11/2022
1Raynaud Disease (Raynaud's Disease)
11/2022
1Fever (Fevers)
02/2022
1Headache (Headaches)
02/2022
1Cardiovascular Diseases (Cardiovascular Disease)
05/2021
1Diarrhea
03/2021
1Pulmonary Arterial Hypertension
01/2021
1Infections
01/2021
1Myositis (Idiopathic Inflammatory Myopathies)
01/2021
1Emphysema
01/2021
1Critical Illness (Critically Ill)
01/2021
1Fatigue
11/2020
1Ulcerative Colitis
01/2020
1Hemorrhage
01/2020
1Human Influenza (Influenza)
01/2020
1Sleep Apnea Syndromes (Sleep Apnea)
01/2020
1Obstructive Sleep Apnea
01/2020
1Mediastinal Emphysema (Pneumomediastinum)
09/2019
1Newborn Respiratory Distress Syndrome
09/2019
1Thrombocytopenia (Thrombopenia)
01/2019

Drug/Important Bio-Agent (IBA)

10nintedanibIBA
03/2022 - 05/2015
10pirfenidoneIBA
10/2021 - 07/2011
7Adrenal Cortex Hormones (Corticosteroids)IBA
12/2021 - 11/2006
7Oxygen (Dioxygen)IBA
01/2021 - 11/2015
5Pharmaceutical PreparationsIBA
02/2022 - 12/2002
5Carbon MonoxideIBA
01/2022 - 03/2011
5ThrombomodulinIBA
01/2020 - 08/2015
5CollagenIBA
01/2020 - 03/2007
4Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2010
4Indicators and Reagents (Reagents)IBA
10/2017 - 01/2013
3AntibodiesIBA
11/2022 - 01/2016
3Monoclonal AntibodiesIBA
02/2022 - 01/2021
3Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA
11/2020 - 07/2012
3Tyrosine Kinase InhibitorsIBA
12/2016 - 01/2014
2Albumin-Bound PaclitaxelFDA Link
02/2022 - 01/2018
2Bleomycin (Blenoxane)FDA LinkGeneric
01/2022 - 07/2012
2AutoantibodiesIBA
01/2022 - 12/2015
2Peptides (Polypeptides)IBA
01/2022 - 01/2020
2MethylprednisoloneFDA LinkGeneric
12/2021 - 11/2018
24-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
11/2021 - 01/2017
2Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA
01/2021 - 03/2020
2Gefitinib (Iressa)FDA Link
09/2018 - 04/2006
2ErbB Receptors (EGF Receptor)IBA
01/2012 - 04/2006
1VaccinesIBA
08/2022
1Paclitaxel (Taxol)FDA LinkGeneric
02/2022
1casirivimab and imdevimab drug combinationIBA
02/2022
1favipiravirIBA
12/2021
1RNA-Binding Proteins (RNA-Binding Protein)IBA
12/2021
1Dexamethasone (Maxidex)FDA LinkGeneric
12/2021
1Anti-Bacterial Agents (Antibiotics)IBA
10/2021
1Antitussive Agents (Antitussives)FDA Link
10/2021
1EnzymesIBA
01/2021
1ImmunosorbentsIBA
01/2021
1Acetylcysteine (Siran)FDA LinkGeneric
01/2021
1InterleukinsIBA
01/2021
1Mitochondrial DNA (mtDNA)IBA
01/2021
1Phosphodiesterase 5 InhibitorsIBA
01/2021
1Angiopoietin-1IBA
01/2021
1lebrikizumabIBA
01/2021
1Ligases (Synthetase)IBA
03/2020
1SteroidsIBA
01/2020
1Mesalamine (Mesalazine)FDA LinkGeneric
01/2020
1Immune Checkpoint InhibitorsIBA
11/2019
1prednylidene (Pred)IBA
07/2019
1DNA (Deoxyribonucleic Acid)IBA
01/2019
1Tacrolimus (Prograf)FDA LinkGeneric
11/2018

Therapy/Procedure

18Therapeutics
02/2022 - 02/2005
9Traction
01/2021 - 06/2002
6Noninvasive Ventilation
01/2021 - 01/2010
5Drug Therapy (Chemotherapy)
03/2022 - 05/2006
3Artificial Respiration (Mechanical Ventilation)
01/2021 - 01/2010
2Positive-Pressure Respiration (Positive End-Expiratory Pressure)
01/2020 - 03/2018
1Cannula
02/2020
1Continuous Positive Airway Pressure
01/2020